lonafarnib: Clinical Trials

13 trials of lonafarnib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 terminated, 1 active not recruiting, 1 enrolling by invitation. 13 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 113Completed 6, Terminated 3, Active not recruiting 1, Enrolling by invitation 1, Unknown 1, Withdrawn 1
Phase 22Enrolling by invitation 1, Terminated 1

Follow lonafarnib: new trials by email Literature Review of lonafarnib trials Research Report on lonafarnib

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Everolimus and lonafarnib - Progeria
Phase 1 / Phase 2Enrolling by invitationBoston Children's Hospital802015-12-012026-04-02
A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)
Docetaxel plus lonafarnib - Prostate Cancer, Breast Cancer
Phase 1 / Phase 2TerminatedMerck Sharp & Dohme LLC52007-06-012015-02-05
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Lonafarnib, Docetaxel - Lung Cancer, Soft Tissue Sarcoma
Phase 1TerminatedEmory University382006-01-012012-12-18
PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
Temodar and SCH 66336 - Gliosarcoma, Glioblastoma
Phase 1CompletedDuke University372005-10-012013-02-20
4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC)
Fenretinide (4-HPR), SCH66336 - Head and Neck Cancer
Phase 1TerminatedM.D. Anderson Cancer Center12005-01-202018-11-15
Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide
Lonafarnib, Temozolomide - Malignant Supratentorial Neoplasm, Recurrent Glioblastoma
Phase 1Active not recruitingM.D. Anderson Cancer Center342004-12-212024-10-17
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
lonafarnib, temozolomide - Brain and Central Nervous System Tumors
Phase 1UnknownEuropean Organisation for Research and Treatment of Cancer - EORTC302004-03-012015-02-10
Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
trastuzumab, lonafarnib, paclitaxel - Breast Cancer
Phase 1CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC232003-08-012012-09-12
Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia
Lonafarnib (SCH66336), Imatinib Mesylate (Gleevec) - Chronic Myelogenous Leukemia
Phase 1CompletedM.D. Anderson Cancer Center232002-11-012018-11-07
SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors
lonafarnib - Brain and Central Nervous System Tumors
Phase 1CompletedPediatric Brain Tumor Consortium532002-01-012009-10-14
SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver
SCH 66336, conventional surgery - Colorectal Cancer, Metastatic Cancer
Phase 1WithdrawnM.D. Anderson Cancer Center1999-09-292018-11-14
A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer
SCH66336 - Carcinoma, Squamous Cell, Cancer of Head and Neck
Phase 1CompletedM.D. Anderson Cancer Center371999-06-012018-10-30
Combination Chemotherapy in Treating Patients With Advanced Cancer
fluorouracil, leucovorin calcium, lonafarnib - Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedMemorial Sloan Kettering Cancer Center251999-04-012013-04-04

Conditions studied

Astrocytoma (3)  ·  Breast Neoplasms (3)  ·  Glioblastoma (3)  ·  Gliosarcoma (3)  ·  Oligodendroglioma (3)  ·  Brain Neoplasms (2)  ·  Central Nervous System Neoplasms (2)  ·  Colorectal Neoplasms (2)  ·  Glioma (2)  ·  Head and Neck Neoplasms (2)  ·  Lung Neoplasms (2)  ·  Prostatic Neoplasms (2)  ·  Breast Neoplasms, Male (1)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Squamous Cell (1)

Sponsors

M.D. Anderson Cancer Center (5)  ·  European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Boston Children's Hospital (1)  ·  Duke University (1)  ·  Emory University (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Pediatric Brain Tumor Consortium (1)

Countries

United States (9)  ·  France (2)  ·  Belgium (1)  ·  Netherlands (1)  ·  Switzerland (1)

Top investigators

Annick Desjardins, MD (1)  ·  Edward S Kim, MD (1)  ·  Jan H. M. Schellens, MD, PhD (1)  ·  John Kauh, MD (1)  ·  Jorge E. Cortes, MD (1)  ·  Leonard B. Saltz, MD (1)  ·  Mario Campone, MD (1)  ·  Mark W. Kieran, MD, PhD (1)  ·  Monica Kleinman, M.D. (1)  ·  Steven A. Curley, MD (1)  ·  Vinay Puduvalli (1)

Results publications

PMID 17634493